EDGAR Filing Documents for 0001193125-24-039982

Form S-8 - Securities to be offered to employees in employee benefit plans:

SEC Accession No. 0001193125-24-039982

Filing Date

2024-02-20

Accepted

2024-02-20 16:16:50

Documents

Effectiveness Date

2024-02-20

Document Format Files

Seq	Description	Document	Type	Size
1	S-8	d752817ds8.htm	S-8	59723
2	EX-5.1	d752817dex51.htm	EX-5.1	9367
3	EX-23.1	d752817dex231.htm	EX-23.1	2106
4	EX-99.1	d752817dex991.htm	EX-99.1	93605
5	EX-99.2	d752817dex992.htm	EX-99.2	138722
6	EX-99.3	d752817dex993.htm	EX-99.3	85844
7	EX-FILING FEES	d752817dexfilingfees.htm	EX-FILING FEES	24405
8	GRAPHIC	g752817g0216010632054.jpg	GRAPHIC	2255
	Complete submission text file	0001193125-24-039982.txt		418380

Mailing Address 535 W 24TH STREET 5TH FLOOR NEW YORK NY 10011

Business Address 535 W 24TH STREET 5TH FLOOR NEW YORK NY 10011 (877) 237-5020

Neurogene Inc. (Filer) CIK: 0001404644 (see all company filings)

IRS No.: 980542593 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-277186 | Film No.: 24653528
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)